161

Public Health & Prevention
Focuses on global human health and epidemic prevention.
Sub Categories on Public Health & Prevention
Latest Articles
Study links key gene to protection from severe illness and death from COVID infections in men under age 75

Study links key gene to protection from severe illness and death from COVID infections in men under age 75

by David March,NYU Langone HealthGraphical Abstract. Credit:The Journal of Infectious Diseases(2024). DOI: 10.1093/infdis/jiae031A certain variant of a key anti-inflammatory gene pro

Study links key gene to protection from severe illness and death from COVID infections in men under age 75

by David March,NYU Langone HealthGraphical Abstract. Credit:The Journal of Infectious Diseases(2024). DOI: 10.1093/infdis/jiae031A certain variant of a key anti-inflammatory gene pro
SARS-CoV-2 induces inflammation, cytokine storm and stress in infected lung cells

SARS-CoV-2 induces inflammation, cytokine storm and stress in infected lung cells

by Heinrich-Heine University DuesseldorfThe coronavirus SARS-CoV-2 docks with its spike protein onto the receptor-ACE2 found on the surface of lung cells. The levels of co-expressed genes with the hum

SARS-CoV-2 induces inflammation, cytokine storm and stress in infected lung cells

by Heinrich-Heine University DuesseldorfThe coronavirus SARS-CoV-2 docks with its spike protein onto the receptor-ACE2 found on the surface of lung cells. The levels of co-expressed genes with the hum
Study reveals low COVID-19 transmission rate from mothers to newborns

Study reveals low COVID-19 transmission rate from mothers to newborns

by SingHealthAnnex A. Credit: KK Women's and Children's HospitalAstudyby KK Women's and Children's Hospital (KKH), Singapore General Hospital (SGH) and National Univer

Study reveals low COVID-19 transmission rate from mothers to newborns

by SingHealthAnnex A. Credit: KK Women's and Children's HospitalAstudyby KK Women's and Children's Hospital (KKH), Singapore General Hospital (SGH) and National Univer
COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant

COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant

by Washington University School of MedicineCredit: Pixabay/CC0 Public DomainPeople who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors—a class of immunosuppressants used

COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant

by Washington University School of MedicineCredit: Pixabay/CC0 Public DomainPeople who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors—a class of immunosuppressants used
Protective antibody targets conserved site of fusion glycoprotein of respiratory syncytial virus

Protective antibody targets conserved site of fusion glycoprotein of respiratory syncytial virus

by Tsinghua University PressHuman neutralizing antibodies against RSV are isolated from the convalescent children. One potent monoclonal antibody RV11 potently neutralizes and prevent RSV infection, w

Protective antibody targets conserved site of fusion glycoprotein of respiratory syncytial virus

by Tsinghua University PressHuman neutralizing antibodies against RSV are isolated from the convalescent children. One potent monoclonal antibody RV11 potently neutralizes and prevent RSV infection, w
SARS-CoV-2 variants, including mutated variants resembling omicron, are evolving new ways to evade antibodies, vaccines

SARS-CoV-2 variants, including mutated variants resembling omicron, are evolving new ways to evade antibodies, vaccines

by Jake Miller,Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainIn an effort to predict future evolutionary maneuvers of SARS-CoV-2, a research team led by investigators at Harvard Medical

SARS-CoV-2 variants, including mutated variants resembling omicron, are evolving new ways to evade antibodies, vaccines

by Jake Miller,Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainIn an effort to predict future evolutionary maneuvers of SARS-CoV-2, a research team led by investigators at Harvard Medical
HIV infection leaves a 'memory' in cells

HIV infection leaves a 'memory' in cells

by George Washington UniversityImage of HIV. Credit: C. GoldsmithContent Providers: CDC/ C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManusThough antiretroviral therapy has made HIV a manageab

HIV infection leaves a 'memory' in cells

by George Washington UniversityImage of HIV. Credit: C. GoldsmithContent Providers: CDC/ C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManusThough antiretroviral therapy has made HIV a manageab
Study reveals clues to how Eastern equine encephalitis virus invades brain cells

Study reveals clues to how Eastern equine encephalitis virus invades brain cells

byWashington University School of MedicineCredit: Pixabay/CC0 Public DomainAn atomic-level investigation of how Eastern equine encephalitis virus binds to a key receptor and gets inside of cells

Study reveals clues to how Eastern equine encephalitis virus invades brain cells

byWashington University School of MedicineCredit: Pixabay/CC0 Public DomainAn atomic-level investigation of how Eastern equine encephalitis virus binds to a key receptor and gets inside of cells
How SARS-CoV-2 evades the immune system

How SARS-CoV-2 evades the immune system

by Hokkaido UniversityThe expression of the immune response gene NLRC5 (red purple) is suppressed in SARS-CoV-2 (green) infected cells (Photo: Koichi Kobayashi). Credit: Koichi KobayashiResearche

How SARS-CoV-2 evades the immune system

by Hokkaido UniversityThe expression of the immune response gene NLRC5 (red purple) is suppressed in SARS-CoV-2 (green) infected cells (Photo: Koichi Kobayashi). Credit: Koichi KobayashiResearche
Drug repurposing research offers new hope in the fight against RSV

Drug repurposing research offers new hope in the fight against RSV

by Jan Grabowski, Zentrum für Experimentelle und Klinische InfektionsforschungIdentification of drug repurposing candidates.AScreening and validation procedure.BHEp-2 cells wer

Drug repurposing research offers new hope in the fight against RSV

by Jan Grabowski, Zentrum für Experimentelle und Klinische InfektionsforschungIdentification of drug repurposing candidates.AScreening and validation procedure.BHEp-2 cells wer
New class of antivirals works against broad range of RNA viruses including SARS-CoV-2

New class of antivirals works against broad range of RNA viruses including SARS-CoV-2

by Gillian Rutherford,University of AlbertaWnt/β-catenin pathway inhibitors enhance induction of type I and III interferons in response to viral infection. A549 cells were treated with DMSO alon

New class of antivirals works against broad range of RNA viruses including SARS-CoV-2

by Gillian Rutherford,University of AlbertaWnt/β-catenin pathway inhibitors enhance induction of type I and III interferons in response to viral infection. A549 cells were treated with DMSO alon
HIV-1 protein suppresses immune response more broadly than thought

HIV-1 protein suppresses immune response more broadly than thought

by eLifeHIV-1 Virus. Credit: J Roberto Trujillo/WikipediaScientists have revealed how a protein produced by HIV-1 plays a broader role in suppressing the immune system's response to infection

HIV-1 protein suppresses immune response more broadly than thought

by eLifeHIV-1 Virus. Credit: J Roberto Trujillo/WikipediaScientists have revealed how a protein produced by HIV-1 plays a broader role in suppressing the immune system's response to infection